Fact CheckerSign in

NCT07524023Active, not recruiting

Emotional-distress-based Integrated Care Programme in Patients With Stable COPD

Emotional-distress-based Integrated Care Programme in Patients With Stable COPD - A Feasibility Study (EmoD-2)

Source: ClinicalTrials.gov · Last updated 17 Jun 2026

Brief summary (registry, in English)

The investigators have developed a new counselling service that focuses on the emotional distress experienced by people living with chronic obstructive pulmonary disease (\*COPD\*). The new programme is led by an advanced practice nursing (\*APN\*) team. Other professionals are involved in the programme, such as medical staff and physiotherapists. The new counselling service lasts three months. Patients will receive ten counselling sessions with a specialized nurse. The overall objective of the study is to assess the feasibility of the newly developed emotional-distress-based integrated care programme.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
15 (estimated)
First submitted
27 Feb 2026
Start date
16 Mar 2026
Primary completion date
10 Sept 2026
Lead sponsor
University of Zurich
Diseases
COPD
NCT number
NCT07524023

What you commit to

  • Study type: Interventional
  • Planned participants: 15
  • From 16 Mar 2026 to the primary completion date, 10 Sept 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Lung transplant (recipient or candidate)

Other illness

  • Cognitive impairment (dementia, delirium)
  • Unstable psychiatric situation, i.e., current psychiatric treatment due to personality disorder, schizophrenia, drug use, suicidal tendencies. No exclusion for nicotine and alcohol abuse, anxiety, and depression

Other

  • Significant changes in symptoms over the past 3 months that exceeded the everyday fluctuations and required intensification of treatment (moderate, severe exacerbations or pneumonia) and no COPD-related hospitalisation in the past 3 months
  • Not speaking or reading German
  • Intervention via telephone or video call not possible

Who the study is looking for

  • Patients with a confirmed diagnosis of COPD (GOLD 1-4) and existing lung function in the past 12 months
  • Age ≥ 18
  • Outpatient treatment on the pneumology clinic of the university hospital Zurich. Last consultation within the past 12 months

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Hospital Zurich
Coordinator of this site? Confirm its status
ZurichSwitzerlandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.